Although herbal formulations and extracts derived from TCM have demonstrated great potential in regulating the PI3K/AKT pathway for treating AD, corresponding clinical studies are still lacking, particularly those on individual Chinese herbal compounds. This evidence concerns the gene AKT1 and Alzheimer disease.